Generation Bio Co.
GBIO
$0.3908
$0.01654.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.89M | 18.58M | 13.17M | 9.96M | 5.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.89M | 18.58M | 13.17M | 9.96M | 5.90M |
| Cost of Revenue | 47.77M | 57.14M | 63.71M | 69.10M | 76.94M |
| Gross Profit | -27.88M | -38.56M | -50.54M | -59.14M | -71.04M |
| SG&A Expenses | 51.59M | 58.99M | 61.66M | 65.26M | 67.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.37M | 116.13M | 125.37M | 134.36M | 144.47M |
| Operating Income | -79.47M | -97.55M | -112.19M | -124.40M | -138.56M |
| Income Before Tax | -131.67M | -145.47M | -158.43M | -169.06M | -126.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -131.67 | -145.47 | -158.43 | -169.06 | -126.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -131.67M | -145.47M | -158.43M | -169.06M | -126.61M |
| EBIT | -79.47M | -97.55M | -112.19M | -124.40M | -138.56M |
| EBITDA | -74.54M | -92.47M | -107.00M | -119.16M | -133.30M |
| EPS Basic | -1.98 | -2.19 | -2.39 | -2.56 | -1.97 |
| Normalized Basic EPS | -0.65 | -0.81 | -0.94 | -1.06 | -1.23 |
| EPS Diluted | -1.98 | -2.19 | -2.39 | -2.56 | -1.97 |
| Normalized Diluted EPS | -0.65 | -0.81 | -0.94 | -1.06 | -1.23 |
| Average Basic Shares Outstanding | 266.49M | 265.77M | 264.93M | 264.06M | 257.86M |
| Average Diluted Shares Outstanding | 266.49M | 265.77M | 264.93M | 264.06M | 257.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |